Pancreatic Cancer: Clinical Significance of Biomarkers
Gastrointestinal Tumors · 2014
DOI: 10.1159/000354996 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gastrointestinal Tumors, 2014. Verfasst von Kenoki Ohuchida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan ; Department of Advanced Medical Initiativ…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background: Improvement in the prognosis of patients with pancreatic cancer, novel effective screening and diagnostic strategies and treatments are needed. Recent advances in the understanding of pancreatic carcinogenesis and tumor microenvironment have allowed identification of biomarkers for screening, diagnosis and prediction of cancer treatments, including novel therapies targeting specific cancer or stromal cell subpopulations. Personalized therapy in pancreatic cancer is also promising as several drugs such as S1, capecitabine and gemcitabine reportedly have significant therapeutic effects. Predictive markers are thus needed to select patients most likely to benefit from therapies based on gemcitabine or other drugs. Summary: We review the clinical significance of promising screening, diagnostic, predictive and prognostic biomarkers based on genetic and epigenetic alterations and microRNA abnormalities in pancreatic cancer. We also review new types of biomarkers based on stromal cells, such as pancreatic stellate cells, in the microenvironment of pancreatic cancer. Key Message Recent advances in our understanding of pancreatic carcinogenesis and the tumor microenvironment have enabled the identification of biomarkers that can be used for screening, diagnosis and prediction of therapeutic response, including the response to novel agents targeting specific cancer cell subpopulations. Practical Implications Although genetic mutations (found in K-ras, p53and p16INK4A) as well as high levels of telomerase activity are frequently associated with pancreatic cancer, their applicability as biomarkers for clinical use has not yet been established. Microarray studies have identified several proteins related to pancreatic cancer. Several of these molecules, such as S100P, MUC1 and MUC5AC, can be quantified in plasma and other body fluids, indicating their utility as potential biomarkers. Research on gemcitabine resistance has uncovered several candidate markers, including genes related to the metabolism and transport of gemcitabine, which may provide a means for identifying those patients who will not benefit from gemcitabine therapy. MicroRNA (miRNA) profiling has revealed an array of miRNAs that are differentially expressed: for example, miR-142-5p and miR-204 may be predictors of response to gemcitabine-based therapy in patients with resected pancreatic cancer. Molecules secreted by pancreatic stellate cells, such as CD10 and CD271, could provide novel targets for the cell-specific management of pancreatic cancer. The use of duodenal juice provides a promising new approach in pancreatic cancer screening.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan ; Department of Advanced Medical Initiatives, Graduate School of Medical Sciences, Kyushu University, Fukuoka, J…
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Advanced Medical Initiatives, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Zitieren
APA
Ohuchida, K., Ohtsuka, T., Mizumoto, K., Hashizume, M., & Tanaka, M. (2014). Pancreatic Cancer: Clinical Significance of Biomarkers. Gastrointestinal Tumors. https://doi.org/10.1159/000354996
Vancouver
Ohuchida K, Ohtsuka T, Mizumoto K, Hashizume M, Tanaka M. Pancreatic Cancer: Clinical Significance of Biomarkers. Gastrointestinal Tumors. 2014. doi:10.1159/000354996
BibTeX
@article{Ohuchida2014,
author = {Ohuchida, Kenoki and Ohtsuka, Takao and Mizumoto, Kazuhiro and Hashizume, Makoto and Tanaka, Masao},
title = {Pancreatic Cancer: Clinical Significance of Biomarkers},
journal = {Gastrointestinal Tumors},
year = {2014},
doi = {10.1159/000354996}
}
EUVIMED